Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Aug 12, 2021 6:10pm
108 Views
Post# 33698393

House Positions Today

House Positions Today
House Positions for C:ARCH from 20210812 to 20210812
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 90,700 151,196 1.667 18,700 31,192 1.668 72,000 -120,004
2 RBC 39,600 65,667 1.658 3,908 6,576 1.683 35,692 -59,091
89 Raymond James 10,000 16,600 1.66 200 340 1.70 9,800 -16,260
79 CIBC 8,300 13,395 1.614 4,700 7,597 1.616 3,600 -5,798
7 TD Sec 9,953 16,461 1.654 8,407 14,020 1.668 1,546 -2,441
80 National Bank 138 233 1.688 0   138 -233
85 Scotia 924 1,535 1.661 1,000 1,600 1.60 -76 65
124 Questrade 0   500 840 1.68 -500 840
57 Interactive 0   1,000 1,540 1.54 -1,000 1,540
13 Instinet 0   1,500 2,505 1.67 -1,500 2,505
88 Credential 0   3,000 4,980 1.66 -3,000 4,980
33 Canaccord 0   6,000 10,140 1.69 -6,000 10,140
14 ITG 3,000 5,085 1.695 16,500 27,555 1.67 -13,500 22,470
9 BMO Nesbitt 2,700 4,563 1.69 16,500 26,790 1.624 -13,800 22,227
1 Anonymous 38,100 63,642 1.67 121,500 202,702 1.668 -83,400 139,060
TOTAL 203,415 338,377 1.663 203,415 338,377 1.663 0 0
 

<< Previous
Bullboard Posts
Next >>